Consolidated Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-63,610
| Closed | -$1.8M | – | 49 |
|
|
2022
Q4 | $1.8M | Sell |
63,610
-14,338
| -18% | -$405K | 1.07% | 36 |
|
|
2022
Q3 | $2.56M | Buy |
77,948
+21,037
| +37% | +$691K | 1.61% | 19 |
|
|
2022
Q2 | $1.79M | Sell |
56,911
-26,218
| -32% | -$826K | 1.07% | 32 |
|
|
2022
Q1 | $3.82M | Buy |
83,129
+32,111
| +63% | +$1.47M | 1.73% | 26 |
|
|
2021
Q4 | $3.12M | Buy |
51,018
+2,549
| +5% | +$156K | 1.38% | 25 |
|
|
2021
Q3 | $3.62M | Buy |
48,469
+2,063
| +4% | +$154K | 1.7% | 25 |
|
|
2021
Q2 | $4.29M | Sell |
46,406
-7,023
| -13% | -$650K | 1.98% | 23 |
|
|
2021
Q1 | $4.74M | Buy |
+53,429
| New | +$4.74M | 2.36% | 20 |
|